Zepbound vs Wegovy trial and compounded GLP-1s
Docs Who Lift
00:00
Intro
This chapter examines the SURMOUNT-5 trial findings, comparing the efficacy of Zepbound and Wegovy for obesity treatment. It also discusses the implications of recent ADA discussions on GLP-1 agonists and upcoming FDA legislative changes affecting diabetes and obesity interventions.
Transcript
Play full episode
